{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:47:05Z","timestamp":1784004425367,"version":"3.55.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Czech Health Research Council","doi-asserted-by":"crossref","award":["NV18-04-00455 and 16-29900A"],"award-info":[{"award-number":["NV18-04-00455 and 16-29900A"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11064-020-03176-y","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T10:09:21Z","timestamp":1605694161000},"page":"411-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer\u2019s Disease in a Central European Population"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-2799","authenticated-orcid":false,"given":"Vladimir J.","family":"Balcar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Janout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Janoutov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"\u0160er\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"3176_CR1","first-page":"168","volume":"32","author":"M Gatz","year":"2012","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johanson B, Mortimer JA, Berg S, Fiske A, Pedersen L (2012) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 32:168\u2013174","journal-title":"Arch Gen Psychiatry"},{"key":"3176_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5507\/bp.2012.055","volume":"156","author":"J Povov\u00e1","year":"2012","unstructured":"Povov\u00e1 J, Ambroz P, Bar M, Pavukov\u00e1 V, \u0160er\u00fd O, Tom\u00e1\u0161kov\u00e1 H, Janout V (2012) Epidemiological of and risk factors for Alzheimer\u2019s disease: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156:108\u2013114. https:\/\/doi.org\/10.5507\/bp.2012.055","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"3176_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/fn.2013.34190","volume":"51","author":"O \u0160er\u00fd","year":"2013","unstructured":"\u0160er\u00fd O, Povov\u00e1 J, M\u00ed\u0161ek I, Pe\u0161\u00e1k L, Janout V (2013) Molecular mechanisms of neuropathological changes in Alzheimer\u2019s disease: a review. Folia Neuropathol 51:1\u20139. https:\/\/doi.org\/10.5114\/fn.2013.34190","journal-title":"Folia Neuropathol"},{"key":"3176_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener 15:40. https:\/\/doi.org\/10.1186\/s13024-020-00391-7","journal-title":"Mol Neurodegener"},{"key":"3176_CR5","first-page":"359","volume":"35","author":"O \u0160er\u00fd","year":"2014","unstructured":"\u0160er\u00fd O, Povov\u00e1 J, Balcar VJ (2014) Perspectives in genetic prediction of Alzheimer\u2019s disease. Neuroendocrinol Lett 35:359\u2013366","journal-title":"Neuroendocrinol Lett"},{"key":"3176_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jns.2016.01.022","volume":"362","author":"O \u0160er\u00fd","year":"2016","unstructured":"\u0160er\u00fd O, Hlineck\u00e1 L, Povov\u00e1 J, Bonczek O, Zeman T, Janout V, Ambroz P, Khan NA, Balcar VJ (2016) Arachidonate 5-lipoxygenase (ALOXAP5) gene polymorphism is associated with Alzheimer\u2019s disease and body mass index. J Neurol Sci 362:27\u201332. https:\/\/doi.org\/10.1016\/j.jns.2016.01.022; see corrigendum in: J Neurol Sci 366:135. https:\/\/doi.org\/10.1016\/j.jns.2016.05.008","journal-title":"J Neurol Sci"},{"key":"3176_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biochi.2017.01.009","volume":"135","author":"O \u0160er\u00fd","year":"2017","unstructured":"\u0160er\u00fd O, Janoutov\u00e1 J, Ewerlingov\u00e1 L, H\u00e1lov\u00e1 A, Lochman J, Janout V, Khan NA, Balcar VJ (2017) CD36 gene polymorphism is associated with Alzheimer disease. Biochimie 135:46\u201353. https:\/\/doi.org\/10.1016\/j.biochi.2017.01.009","journal-title":"Biochimie"},{"issue":"38","key":"3176_CR8","doi-asserted-by":"publisher","first-page":"e12470","DOI":"10.1097\/MD.0000000000012470","volume":"97","author":"L Zhou","year":"2018","unstructured":"Zhou L, Li H-Y, Wang J-H, Deng ZZ, Shan YL, Tan S, Shi YH, Zhang MX, Liu SX, Zhang BJ, Hong MF, Lu ZQ, Huang XM (2018) Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease. A case-control study. Medicine (Baltimore) 97(38):e12470. https:\/\/doi.org\/10.1097\/MD.0000000000012470","journal-title":"Medicine (Baltimore)"},{"key":"3176_CR9","unstructured":"\u0160er\u00fd O, Goswami N, Balcar VJ (2020) Chapter 4: CD36 gene polymorphisms and Alzheimer\u2019s disease. In: Martin C, Preedy V (eds) Neuroscience of dementia: genetics, behaviour and diet in dementia. I. Genetics, molecular & cellular biology. ISBN: 9780128160435 Elsevier (\u00a9 Academic Press). Published 1 Aug 2020"},{"key":"3176_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-018-0444-2","volume":"25","author":"A H\u00e1lov\u00e1","year":"2018","unstructured":"H\u00e1lov\u00e1 A, Janoutov\u00e1 J, Ewerlingov\u00e1 L, Janout V, Bonczek O, Zeman T, Gerguri T, Balcar VJ, \u0160er\u00fd O (2018) CHAT gene polymorphism rs3810950 is associated with the risk of Alzheimer\u2019s disease in the Czech population. J Biomed Sci 25:41. https:\/\/doi.org\/10.1186\/s12929-018-0444-2","journal-title":"J Biomed Sci"},{"key":"3176_CR11","doi-asserted-by":"publisher","unstructured":"Zeman T, Balcar VJ, Cahov\u00e1 K, Janoutov\u00e1 J, Janout V, Lochman J, \u0160er\u00fd O (2020) Polymorphism rs11867353 of tyrosine kinase non-receptor 1 (TNK1) gene is a novel genetic marker for Alzheimer\u2019s disease. Mol Neurobiol (in press). https:\/\/doi.org\/10.1007\/s12035-020-02153-4","DOI":"10.1007\/s12035-020-02153-4"},{"key":"3176_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/CIA.S105769","volume":"11","author":"M Giri","year":"2016","unstructured":"Giri M, Zhang M, Lu Y (2016) Genes associated with Alzheimer\u2019s disease: an overview and current status. Clin Interv Aging 11:665\u2013681","journal-title":"Clin Interv Aging"},{"key":"3176_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","volume":"138","author":"A De Roeck","year":"2019","unstructured":"De Roeck A, van Broekhoven C, Sleegels K (2019) The role of ABCA7 in Alzheimer\u2019s disease: evidence from genomics, transriptomics and methylomics. Acta Neuropathol 138:201\u2013220","journal-title":"Acta Neuropathol"},{"key":"3176_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SC (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507\u2013537. https:\/\/doi.org\/10.1146\/annurev.genom.1.1.507","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"3176_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41398-018-0221-8","volume":"8","author":"H Stocker","year":"2018","unstructured":"Stocker H, M\u00f6llers T, Perna L, Brenner H (2018) The genetic risk of Alzheimer\u2019s disease beyond APOE \u03b54: systematic review of Alzheimer\u2019s genetic risk scores. Transl Psychiatry 8:166. https:\/\/doi.org\/10.1038\/s41398-018-0221-8","journal-title":"Transl Psychiatry"},{"key":"3176_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21037\/tgh.2018.07.13","volume":"3","author":"M Yao","year":"2018","unstructured":"Yao M, Fang M, Zheng W, Dong Z, Yao D (2018) Role of secretory clusterin in hepatocarcinogenesis. Transl Gastroenterol Hepatol 3:48. https:\/\/doi.org\/10.21037\/tgh.2018.07.13","journal-title":"Transl Gastroenterol Hepatol"},{"key":"3176_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/OTT.S58622","volume":"7","author":"T Koltai","year":"2014","unstructured":"Koltai T (2014) Clusterin: a key player in cancer chemoresistance and its inhibition. OncoTargets Ther 7:447\u2013456. https:\/\/doi.org\/10.2147\/OTT.S58622","journal-title":"OncoTargets Ther"},{"key":"3176_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14728222.2017.1267142","volume":"21","author":"M Wilson","year":"2017","unstructured":"Wilson M, Zubeidi A (2017) Clusterin as a therapeutic agent. Expert Opinion Ther Targets 21:201\u2013203","journal-title":"Expert Opinion Ther Targets"},{"key":"3176_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164. https:\/\/doi.org\/10.3389\/fnins.2019.00164","journal-title":"Front Neurosci"},{"key":"3176_CR20","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1074\/jbc.274.11.6875","volume":"274","author":"DT Humphreys","year":"1999","unstructured":"Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR (1999) Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 274:6875\u20136881. https:\/\/doi.org\/10.1074\/jbc.274.11.6875","journal-title":"J Biol Chem"},{"key":"3176_CR21","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1159\/000366365","volume":"34","author":"P Rohne","year":"2014","unstructured":"Rohne P, Prochnow H, Wolf S, Renner B, Koch-Brandt C (2014) The chaperone activity of clusterin is dependent on glycosylation and redox environment. Cell Physiol Biochem 34:1626\u20131639. https:\/\/doi.org\/10.1159\/000366365","journal-title":"Cell Physiol Biochem"},{"key":"3176_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/bmc-2015-0026","volume":"7","author":"P Rohne","year":"2016","unstructured":"Rohne P, Prochnow H, Koch-Brandt C (2016) The CLU-files: disentanglement of a mystery. Biomol Concepts 7:1\u201315. https:\/\/doi.org\/10.1515\/bmc-2015-0026","journal-title":"Biomol Concepts"},{"key":"3176_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000351207","volume":"59","author":"IP Trougakos","year":"2013","unstructured":"Trougakos IP (2013) The molecular chaperone apolipoprotein J\/clusterin as a sensor of oxidative stress: implications in therapeutic approaches\u2014a mini-review. Gerontology 59:514\u2013523. https:\/\/doi.org\/10.1159\/000351207","journal-title":"Gerontology"},{"key":"3176_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11154-013-9275-3","volume":"15","author":"S Park","year":"2014","unstructured":"Park S, Mathis KW, Lee IK (2014) The physiological roles of apolipoprotein J\/clusterin in metabolic and cardiovascular diseases. Rev Endocr Metab Disord 15:45\u201353. https:\/\/doi.org\/10.1007\/s11154-013-9275-3","journal-title":"Rev Endocr Metab Disord"},{"key":"3176_CR25","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.3892\/ol.2018.8186","volume":"15","author":"J Zhong","year":"2018","unstructured":"Zhong J, Yu X, Dong X, Lu H, Zhou W, Li L, Li Z, Sun P, Shi X (2018) Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells. Oncol Lett 15:7191\u20137199. https:\/\/doi.org\/10.3892\/ol.2018.8186","journal-title":"Oncol Lett"},{"key":"3176_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ijc.22327","volume":"120","author":"M Lourda","year":"2007","unstructured":"Lourda M, Trougakos IP, Gonos ES (2007) Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of clusterin\/apolipoprotein J. Int J Cancer 120:611\u2013622. https:\/\/doi.org\/10.1002\/ijc.22327","journal-title":"Int J Cancer"},{"key":"3176_CR27","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1080\/10715760600902310","volume":"40","author":"IP Trougakos","year":"2006","unstructured":"Trougakos IP, Gonos ES (2006) Regulation of clusterin\/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic Res 40:1324\u20131334. https:\/\/doi.org\/10.1080\/10715760600902310","journal-title":"Free Radic Res"},{"key":"3176_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/npp.2013.182","volume":"39","author":"G Gorini","year":"2014","unstructured":"Gorini G, Harris RA, Mayfield RD (2014) Proteomic approaches and identification of novel therapeutic targets for alcoholism. Neuropsychopharmacol Rev 39:104\u2013130. https:\/\/doi.org\/10.1038\/npp.2013.182","journal-title":"Neuropsychopharmacol Rev"},{"key":"3176_CR29","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1073\/pnas.96.12.6745","volume":"96","author":"U Alon","year":"1999","unstructured":"Alon U, Barkai N, Notterman DA, Gish K, Ybarr S, Mack D, Levine AJ (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 96:6745\u20136750","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3176_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/0891988716640373","volume":"29","author":"M Alayl\u0131o\u011flu","year":"2016","unstructured":"Alayl\u0131o\u011flu M, Gezen-Ak D, Dursun E, Bilgi\u00e7 B, Hana\u011fas\u0131 H, Ertan T, G\u00fcrvit H, Emre M, Eker E, Uysal \u00d6, Y\u0131lmazer S (2016) The association between clusterin and APOE polymorphisms and late-onset Alzheimer disease in a Turkish cohort. J Geriatr Psychiatry Neurol 29:221\u2013226. https:\/\/doi.org\/10.1177\/0891988716640373","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"3176_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/s1357-2725(01)00155-8","volume":"34","author":"SE Jones","year":"2002","unstructured":"Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427\u2013431. https:\/\/doi.org\/10.1016\/s1357-2725(01)00155-8","journal-title":"Int J Biochem Cell Biol"},{"key":"3176_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099. https:\/\/doi.org\/10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"3176_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamsher ML, Pahwa JS et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u20131093. https:\/\/doi.org\/10.1038\/ng.440","journal-title":"Nat Genet"},{"key":"3176_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM (2015) Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77:43\u201351. https:\/\/doi.org\/10.1016\/j.biopsych.2014.05.006","journal-title":"Biol Psychiatry"},{"key":"3176_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JAD-130380","volume":"38","author":"SJ Kiddle","year":"2014","unstructured":"Kiddle SJ, Sattlecker M, Proitsi P, Simmons A, Westman E, Bazenet C et al (2014) Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: a systematic review and replication study. J Alzheimers Dis 38:515\u2013531. https:\/\/doi.org\/10.3233\/JAD-130380","journal-title":"J Alzheimers Dis"},{"key":"3176_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0006-8993(92)90071-G","volume":"579","author":"PL McGeer","year":"1992","unstructured":"McGeer PL, Kawamata T, Walker DG (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res 579:337\u2013341","journal-title":"Brain Res"},{"key":"3176_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/bpa.12392","volume":"27","author":"JS Miners","year":"2017","unstructured":"Miners JS, Clarke P, Love S (2017) Clusterin levels are increased in Alzheimer\u2019s disease and influence the regional distribution of A\u03b2. Brain Pathol 27:305\u2013313. https:\/\/doi.org\/10.1111\/bpa.12392","journal-title":"Brain Pathol"},{"key":"3176_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neurobiolaging.2019.10.025","volume":"89","author":"CE Shepherd","year":"2019","unstructured":"Shepherd CE, Affleck AJ, Bahar AY, Crew-Jones F, Halliday GM (2019) Intracellular and secreted forms of clusterin are elevated early in Alzheimer\u2019s disease and associate with both A\u03b2 and tau pathology. Neurobiol Aging 89:129\u2013131. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.025","journal-title":"Neurobiol Aging"},{"key":"3176_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","volume":"50","author":"M Calero","year":"2000","unstructured":"Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J (2000) Apolipoprotein J (clusterin) and Alzheimer\u2019s disease. Microsc Res Tech 50:305\u2013315. https:\/\/doi.org\/10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","journal-title":"Microsc Res Tech"},{"issue":"7","key":"3176_CR40","doi-asserted-by":"publisher","first-page":"e103187","DOI":"10.1371\/journal.pone.0103187","volume":"9","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Hayashi I, Wong J, Tugusheva K, Renger JJ, Zerbinatti C (2014) Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein tau in Alzheimer\u2019s disease. PLoS One 9(7):e103187","journal-title":"PLoS One"},{"key":"3176_CR41","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s11064-018-2600-1","volume":"43","author":"MA Kashem","year":"2018","unstructured":"Kashem MA, Sultana N, Balcar VJ (2018) Exposure of rat neural stem cells to ethanol affects cell numbers and alters expression of 28 proteins. Neurochem Res 43:1841\u20131854. https:\/\/doi.org\/10.1007\/s11064-018-2600-1","journal-title":"Neurochem Res"},{"key":"3176_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11064-015-1605-2","volume":"41","author":"MA Kashem","year":"2016","unstructured":"Kashem MA, Ahmed S, Sultana N, Ahmed EU, Pickford R, Rae C, \u0160er\u00fd O, McGregor IS, Balcar VJ (2016) Metabolomics of neurotransmitters and related metabolites in post-mortem tissue from the dorsal and ventral striatum of alcoholic postmortem human brain. Neurochem Res 41:385\u2013397. https:\/\/doi.org\/10.1007\/s11064-015-1605-2","journal-title":"Neurochem Res"},{"key":"3176_CR43","doi-asserted-by":"publisher","unstructured":"Kashem MA, \u0160er\u00fd O, Pow DL, Rowlands B, Rae CD, Balcar VJ (2020) Actions of alcohol in brain: genetics, metabolomics, GABA receptors, proteomics and glutamate transporter GLAST\/EAAT1. Curr Mol Pharmacol 13 (in press). https:\/\/doi.org\/10.2174\/1874467213666200424155244","DOI":"10.2174\/1874467213666200424155244"},{"key":"3176_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neurobiolaging.2010.04.015","volume":"33","author":"MI Kamboh","year":"2012","unstructured":"Kamboh MI, Minster RL, Demirci FY, Ganguli M, DeKosky ST, Lopez OL, Barmada MM (2012) Association of CLU and PICALM variants with Alzheimer\u2019s disease. Neurobiol Aging 33:518\u2013521. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.015","journal-title":"Neurobiol Aging"},{"key":"3176_CR45","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archneurol.2010.147","volume":"67","author":"MM Carrasquillo","year":"2010","unstructured":"Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F et al (2010) Replication of CLU, CR1, and PICALM associations with Alzheimer\u2019s disease. Arch Neurol 67:961\u2013964. https:\/\/doi.org\/10.1001\/archneurol.2010.147","journal-title":"Arch Neurol"},{"issue":"9518","key":"3176_CR46","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","volume":"367","author":"S Gauthier","year":"2006","unstructured":"Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K et al (2006) Mild cognitive impairment. Lancet 367(9518):1262\u20131270. https:\/\/doi.org\/10.1016\/S0140-6736(06)68542-5","journal-title":"Lancet"},{"key":"3176_CR47","unstructured":"R Development Core Team (2019) R: a language and environment for statistical computing. R Foundation for Statistical\nComputing, Vienna, Austria"},{"key":"3176_CR48","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1007\/s12035-017-0547-x","volume":"55","author":"D Seripa","year":"2018","unstructured":"Seripa D, Panza F, Paroni G, D\u2019Onofrio G, Bisceglia P, Gravina C et al (2018) Role of CLU, PICALM and TNK1 genotypes in aging with and without Alzheimer\u2019s disease. Mol Neurobiol 55:4333\u20134344. https:\/\/doi.org\/10.1007\/s12035-017-0547-x","journal-title":"Mol Neurobiol"},{"key":"3176_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10072-018-3259-8","volume":"39","author":"R Zhu","year":"2018","unstructured":"Zhu R, Liu X, He Z (2018) Association between CLU gene rs11136000 polymorphism and Alzheimer\u2019s disease: an updated meta-analysis. Neurol Sci 39:679\u2013689. https:\/\/doi.org\/10.1007\/s10072-018-3259-8","journal-title":"Neurol Sci"},{"key":"3176_CR50","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. J Amer Med Assoc 303:1832\u20131840. https:\/\/doi.org\/10.1001\/jama.2010.574","journal-title":"J Amer Med Assoc"},{"issue":"4","key":"3176_CR51","doi-asserted-by":"publisher","first-page":"e33923","DOI":"10.1371\/journal.pone.0033923","volume":"7","author":"I-F Ling","year":"2012","unstructured":"Ling I-F, Bhongsatiern J, Simpson JF, Fardo DW, Estus S (2012) Genetics of clusterin isoform expression and Alzheimer\u2019s disease risk. PLoS One 7(4):e33923","journal-title":"PLoS One"},{"key":"3176_CR52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1134\/S0026893310040072","volume":"44","author":"SA Golenkina","year":"2010","unstructured":"Golenkina SA, Gol\u2019tsov AI, Kuznetsov IL, Grigorenko AP, Andreeva TV, Reshetov DA et al (2010) Analysis of clusterin gene (CLU\/APOJ) polymorphism in Alzheimer\u2019s disease patients and in normal cohorts from Russian populations (in Russian). Mol Biol (Moscow) 44:620\u2013626","journal-title":"Mol Biol (Moscow)"},{"key":"3176_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2014.07.042","volume":"36","author":"MM Carrasquillo","year":"2015","unstructured":"Carrasquillo MM, Crook JE, Pedraza O, Thomas CS, Pankratz VS, Allen M et al (2015) Late-onset Alzheimer\u2019s risk variants in memory decline, incident mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging 36:60\u201367. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.042","journal-title":"Neurobiol Aging"},{"key":"3176_CR54","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1176\/appi.ajp.2012.11121815","volume":"169","author":"RA Sweet","year":"2012","unstructured":"Sweet RA, Seltman H, Emanuel JE, Lopez OL, Becker JT, Bis JC et al (2012) Effect of Alzheimer\u2019s disease risk genes on trajectories of cognitive function in the cardiovascular health study. Am J Psychiatry 169:954\u2013962. https:\/\/doi.org\/10.1176\/appi.ajp.2012.11121815","journal-title":"Am J Psychiatry"},{"key":"3176_CR55","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.biopsych.2012.05.026","volume":"73","author":"M Thambisetty","year":"2013","unstructured":"Thambisetty M, Beason-Held LL, An Y, Kraut M, Nalls M, Hernandez DG et al (2013) Alzheimer risk variant CLU and brain function during aging. Biol 73:399\u2013405. https:\/\/doi.org\/10.1016\/j.biopsych.2012.05.026","journal-title":"Biol"},{"key":"3176_CR56","doi-asserted-by":"publisher","first-page":"e48255","DOI":"10.7554\/eLife.48255","volume":"8","author":"SK Herring","year":"2019","unstructured":"Herring SK, Moon HJ, Rawal P, Chhibber A, Zhao L (2019) Brain clusterin protein isoforms and mitochondrial localization. Elife 8:e48255. https:\/\/doi.org\/10.7554\/eLife.48255","journal-title":"Elife"},{"key":"3176_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5115\/acb.2011.44.3.169","volume":"44","author":"N Kim","year":"2011","unstructured":"Kim N, Choi WS (2011) Proapoptotic role of nuclear clusterin in brain. Anat Cell Biol 44:169\u2013175. https:\/\/doi.org\/10.5115\/acb.2011.44.3.169","journal-title":"Anat Cell Biol"},{"key":"3176_CR58","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1007\/s00018-011-0684-8","volume":"68","author":"AR Wyatt","year":"2011","unstructured":"Wyatt AR, Yerbury JJ, Berghofer P, Greguric I, Katsifis A, Dobson CM, Wilson MR (2011) Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell Mol Life Sci 68:3919\u20133931","journal-title":"Cell Mol Life Sci"},{"key":"3176_CR59","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s11033-018-4561-5","volume":"46","author":"M Aghajanpour-Mir","year":"2019","unstructured":"Aghajanpour-Mir M, Amjadi-Moheb F, Dadkhah T, Hosseini SR, Ghadami E, Assadolahi E, Akhavan-Niaki H, Ahangar AA (2019) Informative combination of CLU rs11136000, serum HDL levels, diabetes and age as a new piece of puzzle-picture of predictive medicine for cognitive disorders. Mol Biol Rep 46:1033\u20131041. https:\/\/doi.org\/10.1007\/s11033-018-4561-5","journal-title":"Mol Biol Rep"},{"key":"3176_CR60","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S (2019) miRBase: from microRNA sequences to function. Nucleic Acids Res 47:D155\u2013D162. https:\/\/doi.org\/10.1093\/nar\/gky1141","journal-title":"Nucleic Acids Res"},{"key":"3176_CR61","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","volume":"126","author":"KC Miranda","year":"2006","unstructured":"Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126:1203\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2006.07.031","journal-title":"Cell"},{"key":"3176_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-017-0481-1","volume":"5","author":"JM Gregory","year":"2017","unstructured":"Gregory JM, Whiten DR, Brown RA, Barros TP, Kumita JR, Yerbury JJ et al (2017) Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol Commun 5:81","journal-title":"Acta Neuropathol Commun"},{"key":"3176_CR63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/21678421.2018.1433689","volume":"19","author":"Z Xu","year":"2018","unstructured":"Xu Z, Lee A, Nouwens A, Henderson RD, McCombe PA (2018) Mass spectroscopy analysis of plasma from amyotrophic lateral sclerosis and control subjects. Amyotroph Lat Scler Frontotemp Degener 19:362\u2013376. https:\/\/doi.org\/10.1080\/21678421.2018.1433689","journal-title":"Amyotroph Lat Scler Frontotemp Degener"},{"key":"3176_CR64","doi-asserted-by":"publisher","unstructured":"Mohanty L, Henderson RD, McCombe PA, Lee A (2020) Levels of clusterin, CD5L, ficolin-3 and gelsolin in ALS patients and controls. Amyotroph Lat Scler Frontotemp Degener. https:\/\/doi.org\/10.1080\/21678421.2020.1779303","DOI":"10.1080\/21678421.2020.1779303"},{"key":"3176_CR65","doi-asserted-by":"publisher","first-page":"41235","DOI":"10.1038\/srep41235","volume":"7","author":"SR Matukumalli","year":"2017","unstructured":"Matukumalli SR, Tangirala R, Rao CM (2017) Clusterin: full-length protein and one of its chains show opposing effects on cellular lipid accumulation. Sci Rep 7:41235. https:\/\/doi.org\/10.1038\/srep41235","journal-title":"Sci Rep"},{"issue":"4","key":"3176_CR66","doi-asserted-by":"publisher","first-page":"eaau3112","DOI":"10.1126\/sciadv.aau3112","volume":"5","author":"T Scheidt","year":"2019","unstructured":"Scheidt T, \u0141api\u0144ska U, Kumita JR, Whiten DR, Klenerman D, Wilson MR et al (2019) Secondary nucleation and elongation occur at different sites on Alzheimer\u2019s amyloid-\u03b2 aggregates. Sci Adv 5(4):eaau3112. https:\/\/doi.org\/10.1126\/sciadv.aau3112","journal-title":"Sci Adv"},{"key":"3176_CR67","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.csbj.2019.06.017","volume":"17","author":"P Pic\u00f3n-Pag\u00e8s","year":"2019","unstructured":"Pic\u00f3n-Pag\u00e8s P, Bonet J, Garc\u00eda-Garc\u00eda J, Garcia-Buendia J, Gutierrez D, Valle J (2019) Human albumin impairs amyloid \u03b2-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in Alzheimer\u2019s disease. Comput Struct Biotechnol J 17:963\u2013971. https:\/\/doi.org\/10.1016\/j.csbj.2019.06.017","journal-title":"Comput Struct Biotechnol J"},{"key":"3176_CR68","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1096\/fj.06-7986com","volume":"21","author":"JJ Yerbury","year":"2007","unstructured":"Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillary structures. FASEB J 21:2312\u20132322","journal-title":"FASEB J"},{"key":"3176_CR69","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF03036452","volume":"7","author":"MD Martin-Rehrmann","year":"2005","unstructured":"Martin-Rehrmann MD, Hoe HS, Capuani EM, Rebeck GW (2005) Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer\u2019s disease brain. Neurotox Res 7:231\u2013242. https:\/\/doi.org\/10.1007\/BF03036452","journal-title":"Neurotox Res"},{"key":"3176_CR70","doi-asserted-by":"publisher","first-page":"14243","DOI":"10.1038\/s41598-020-70990-3","volume":"10","author":"S Satapathy","year":"2020","unstructured":"Satapathy S, Dabba RA, Wilson MR (2020) Rapid high-yield expression and purification of fully post-translationally modified recombinant clusterin and mutants. Sci Rep 10:14243. https:\/\/doi.org\/10.1038\/s41598-020-70990-3","journal-title":"Sci Rep"},{"key":"3176_CR71","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2174\/1567205013666160703180531","volume":"13","author":"L Qiu","year":"2016","unstructured":"Qiu L, He Y, Tang H, Zhou Y, Wang J, Zhang W et al (2016) Genetically-mediated grey and white matter alteration in normal elderly individuals with the CLU-C allele gene. Curr Alzheimer Res 13:1302\u20131310. https:\/\/doi.org\/10.2174\/1567205013666160703180531","journal-title":"Curr Alzheimer Res"},{"key":"3176_CR72","first-page":"691","volume":"35","author":"O \u0160er\u00fd","year":"2014","unstructured":"\u0160er\u00fd O, Hlineck\u00e1 L, Balcar VJ, Janout V, Povov\u00e1 J (2014) Diabetes, hypertension and stroke\u2014does Alzheimer protect you? Neuroendocrinol Lett 35:691\u2013696","journal-title":"Neuroendocrinol Lett"},{"key":"3176_CR73","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/01.hjh.0000052472.40108.4e","volume":"21","author":"C Langenberg","year":"2003","unstructured":"Langenberg C, Hardy R, Kuh D, Wadsworth EJ (2003) Influence of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure. J Hypertens 21:537\u2013543. https:\/\/doi.org\/10.1097\/01.hjh.0000052472.40108.4e","journal-title":"J Hypertens"},{"key":"3176_CR74","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/JAD-141884","volume":"44","author":"J Stone","year":"2015","unstructured":"Stone J, Jonstone DM, Mitrofanis J, O\u2019Rourke M (2015) The mechanical cause of age-related dementia (Alzeimer\u2019s disease): the brain is destroyed by the pulse. J Alzheimer\u2019s Dis 44:355\u2013373. https:\/\/doi.org\/10.3233\/JAD-141884","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3176_CR75","doi-asserted-by":"publisher","first-page":"a669","DOI":"10.3389\/fnins.2020.00669","volume":"14","author":"RA Levin","year":"2020","unstructured":"Levin RA, Carnegie MH, Celermajer DS (2020) Pulse pressure: an emerging therapeutic target for dementia. Front Neurosci 14:a669. https:\/\/doi.org\/10.3389\/fnins.2020.00669","journal-title":"Front Neurosci"},{"key":"3176_CR76","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0531-5565(02)00139-0","volume":"37","author":"IP Trougakos","year":"2002","unstructured":"Trougakos IP, Poulakou M, Stathotos M, Chalikia A, Melidonis A, Gonos ES (2002) Serum levels of the senescence biomarker clusterin\/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp Gerontol 37:1175\u20131187","journal-title":"Exp Gerontol"},{"key":"3176_CR77","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.metabol.2017.09.014","volume":"78","author":"JA Seo","year":"2018","unstructured":"Seo JA, Kang MC, Ciaraldi TP, Kim SS, Park KS, Choe C et al (2018) Circulating ApoJ is closely associated with insulin resistance in human subjects. Metabolism 78:155\u2013166","journal-title":"Metabolism"},{"key":"3176_CR78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0021-9150(97)89866-8","volume":"331","author":"IC Gelissen","year":"1998","unstructured":"Gelissen IC, Hochgrebe T, Wilson MR, Easterbrook-Smith SB, Jessup W, Dean RT et al (1998) Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function? Biochem J 331:231\u2013237. https:\/\/doi.org\/10.1016\/S0021-9150(97)89866-8","journal-title":"Biochem J"},{"key":"3176_CR79","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbalip.2017.09.008","volume":"1863","author":"M Zandl-Lang","year":"2018","unstructured":"Zandl-Lang M, Fanaee-Danesh E, Sun Y, Albrecher N, Gali CC (2018) Regulatory effects of simvastatin and ApoJ on APP processing and amyloid-\u03b2 clearance in blood-brain barrier endothelial cells. Biochim Biophys Acta Mol Cell Biol Lipids 1863:40\u201360. https:\/\/doi.org\/10.1016\/j.bbalip.2017.09.008","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"3176_CR80","doi-asserted-by":"publisher","first-page":"a179","DOI":"10.3389\/fnagi.2016.00179","volume":"8","author":"R Cai","year":"2016","unstructured":"Cai R, Han J, Sun J, Huang R, Tian S, Shen Y, Dong X, Xia W, Wang S (2016) Plama clusterin and the CLU gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients. Front Aging Neurosci 8:a179. https:\/\/doi.org\/10.3389\/fnagi.2016.00179","journal-title":"Front Aging Neurosci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03176-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-020-03176-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03176-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T18:42:42Z","timestamp":1612291362000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-020-03176-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3176"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03176-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"7 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors have read and approved the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Informed consent was obtained from all participants or their legal representatives and formal approval for the study was granted by the Ethics Committee of the Faculty of Medicine, University of Ostrava, Czech Republic and by the Ethics Committee of St. Anne\u2019s University Hospital, Brno, Czech Republic. The projects \u201cGenetics and Epidemiology of Alzheimer\u2019s Disease\u201d (EK no. 11\/2015), \u201cGenetics and Epidemiology of Mild Cognitive Disorder\u201d (EK no. 12\/2015) were approved by the Committee on 16th June 2015 and project \u201cThe role of CD36 gene in pathogenesis of Alzheimer\u2019s disease \u201cwas approved by the Ethics Committee of St. Anne\u2019s University Hospital on 29th June 2017.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}